Myfortic vs. Cellcept in Kidney Transplant Recipients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2004
The comparison the incidence of G.I. toxicity between Myfortic® vs. Cellcept® in 150 sequential patients, in which 75 will be randomized to Cellcept® and 75 to Myfortic® in first and second living or deceased donor renal transplant recipients.
Epistemonikos ID: 66f2e2b49fc5238ebbe5146ae0a6632476f9e28f
First added on: May 04, 2024